ArticlePloS one2014

Abrogation of TNFα production during cancer immunotherapy is crucial for suppressing side effects due to the systemic expression of IL-12.

Bibiana Barrios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.